Pyroptosis in Osteoblasts: A Novel Hypothesis Underlying the Pathogenesis of Osteoporosis

• Published in: Frontiers in endocrinology (Lausanne) Vol. 11; p. 548812
• Main Authors: Tao, Zhengbo, Wang, Jinpeng, Wen, Kaicheng, Yao, Renqi, Da, Wacili, Zhou, Siming, Meng, Yan, Qiu, Shui, Yang, Keda, Zhu, Yue, Tao, Lin
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 08.01.2021
• Subjects: Endocrinology; IL-18; IL-1β; NLRP3; osteoporosis; pyroptosis; pyroptosis; NLRP3; IL-1β; osteoporosis; IL-18
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2020.548812

Osteoporosis has become a worldwide disease characterized by a reduction in bone mineral density and the alteration of bone architecture leading to an increased risk of fragility fractures. And an increasing number of studies have indicated that osteoblasts undergo a large number of programmed death events by many different causes in osteoporosis and release NLRP3 and interleukin (e.g., inflammatory factors), which play pivotal roles in contributing to excessive differentiation of osteoclasts and result in exaggerated bone resorption. NLRP3 is activated during pyroptosis and processes the precursors of IL-1β and IL-18 into mature forms, which are released into the extracellular milieu accompanied by cell rupture. All of these compounds are the classical factors of pyroptosis. The cellular effects of pyroptosis are commonly observed in osteoporosis. Although many previous studies have focused on the pathogenesis of these inflammatory factors in osteoporosis, pyroptosis has not been previously evaluated. In this review, pyroptosis is proposed as a novel hypothesis of osteoporosis pathogenesis for the first time, thus providing a new direction for the treatment of osteoporosis in the future.